Target intelligence / Profile preview

Regulator of nonsense transcripts 2 (UPF2)

Target
UPF2
Molecular classification
Other, RNA binding protein, nonsense-mediated mRNA decay factor, mRNA surveillance factor
01

Overview

Regulator of nonsense transcripts 2 (UPF2) is a highly conserved RNA-binding protein and core component of the nonsense-mediated mRNA decay (NMD) pathway, a critical post-transcriptional quality control mechanism in eukaryotic cells. UPF2 acts as a scaffold, facilitating interactions between other NMD factors (notably UPF1 and UPF3b) and the exon junction complex, and is essential for detecting and degrading mRNAs with premature termination codons, thereby preventing the translation of potentially deleterious truncated proteins. The NMD pathway, orchestrated by UPF2, influences overall transcriptome fidelity, regulates alternative splicing, and gene expression, and is crucial during organ development, including in the liver and testes. Loss of UPF2 function leads to impaired cell cycle progression, defective tissue regeneration (e.g., failure of liver regeneration after injury), and, in the testis, results in severe atrophy and male infertility due to the accumulation of aberrant mRNAs and loss of Sertoli and germ cells. UPF2 itself is not currently known to be directly targeted by therapeutic drugs, nor is there substantial evidence associating UPF2 as a biomarker or safety concern in the clinical setting.

Other names
UPF2KIAA1408RENT2hUpf2DKFZP434D222smg-3Up-frameshift suppressor 2 homolognonsense mediated mRNA decay factorHUPF2FRS2/UPF2/LEMD3 fusionLEMD3/UPF2 fusionyeast Upf2p homolog
02

Biological functions

Nonsense-mediated mRNA decay (NMD)mRNA quality controlRegulation of cell cycle progressionRegulation of gene expressionScaffold for exon junction complex assemblySpermatogenesis and testis developmentOrgan development (e.g. liver, testes)
03

Disease associations

Male infertility (due to impaired testicular development and spermatogenesis)Impaired organ development and regeneration (especially liver)Possible impact on cancer, neurodegeneration, other diseases via transcriptome fidelity (speculative, not directly referenced)

Beyond the preview

Go deeper on Regulator of nonsense transcripts 2 (UPF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulator of nonsense transcripts 2 (UPF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call